290 related articles for article (PubMed ID: 20385753)
1. Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci.
Sass V; Schneider T; Wilmes M; Körner C; Tossi A; Novikova N; Shamova O; Sahl HG
Infect Immun; 2010 Jun; 78(6):2793-800. PubMed ID: 20385753
[TBL] [Abstract][Full Text] [Related]
2. Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge.
Sass V; Pag U; Tossi A; Bierbaum G; Sahl HG
Int J Med Microbiol; 2008 Oct; 298(7-8):619-33. PubMed ID: 18455476
[TBL] [Abstract][Full Text] [Related]
3. Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.
Schmitt P; Wilmes M; Pugnière M; Aumelas A; Bachère E; Sahl HG; Schneider T; Destoumieux-Garzón D
J Biol Chem; 2010 Sep; 285(38):29208-16. PubMed ID: 20605792
[TBL] [Abstract][Full Text] [Related]
4. The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions.
Münch D; Müller A; Schneider T; Kohl B; Wenzel M; Bandow JE; Maffioli S; Sosio M; Donadio S; Wimmer R; Sahl HG
J Biol Chem; 2014 Apr; 289(17):12063-12076. PubMed ID: 24627484
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II.
de Leeuw E; Li C; Zeng P; Li C; Diepeveen-de Buin M; Lu WY; Breukink E; Lu W
FEBS Lett; 2010 Apr; 584(8):1543-8. PubMed ID: 20214904
[TBL] [Abstract][Full Text] [Related]
6. Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus.
Münch D; Roemer T; Lee SH; Engeser M; Sahl HG; Schneider T
PLoS Pathog; 2012 Jan; 8(1):e1002509. PubMed ID: 22291598
[TBL] [Abstract][Full Text] [Related]
7. Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
Schneider T; Sahl HG
Curr Opin Investig Drugs; 2010 Feb; 11(2):157-64. PubMed ID: 20112165
[TBL] [Abstract][Full Text] [Related]
8. Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors.
Müller A; Münch D; Schmidt Y; Reder-Christ K; Schiffer G; Bendas G; Gross H; Sahl HG; Schneider T; Brötz-Oesterhelt H
J Biol Chem; 2012 Jun; 287(24):20270-80. PubMed ID: 22514280
[TBL] [Abstract][Full Text] [Related]
9. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
Schneider T; Kruse T; Wimmer R; Wiedemann I; Sass V; Pag U; Jansen A; Nielsen AK; Mygind PH; Raventós DS; Neve S; Ravn B; Bonvin AM; De Maria L; Andersen AS; Gammelgaard LK; Sahl HG; Kristensen HH
Science; 2010 May; 328(5982):1168-72. PubMed ID: 20508130
[TBL] [Abstract][Full Text] [Related]
10. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.
Schneider T; Senn MM; Berger-Bächi B; Tossi A; Sahl HG; Wiedemann I
Mol Microbiol; 2004 Jul; 53(2):675-85. PubMed ID: 15228543
[TBL] [Abstract][Full Text] [Related]
11. Structural Insights into the Mode of Action of the Peptide Antibiotic Copsin.
Franzoi M; van Heuvel Y; Thomann S; Schürch N; Kallio PT; Venier P; Essig A
Biochemistry; 2017 Sep; 56(37):4992-5001. PubMed ID: 28825809
[TBL] [Abstract][Full Text] [Related]
12. Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway.
Henrich E; Ma Y; Engels I; Münch D; Otten C; Schneider T; Henrichfreise B; Sahl HG; Dötsch V; Bernhard F
J Biol Chem; 2016 Jan; 291(5):2535-46. PubMed ID: 26620564
[TBL] [Abstract][Full Text] [Related]
13. Further evidence that a cell wall precursor [C(55)-MurNAc-(peptide)-GlcNAc] serves as an acceptor in a sorting reaction.
Ruzin A; Severin A; Ritacco F; Tabei K; Singh G; Bradford PA; Siegel MM; Projan SJ; Shlaes DM
J Bacteriol; 2002 Apr; 184(8):2141-7. PubMed ID: 11914345
[TBL] [Abstract][Full Text] [Related]
14. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
Brötz H; Bierbaum G; Reynolds PE; Sahl HG
Eur J Biochem; 1997 May; 246(1):193-9. PubMed ID: 9210483
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of peptidoglycan biosynthesis by ramoplanin.
Somner EA; Reynolds PE
Antimicrob Agents Chemother; 1990 Mar; 34(3):413-9. PubMed ID: 2334153
[TBL] [Abstract][Full Text] [Related]
16. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus.
Schibli DJ; Hunter HN; Aseyev V; Starner TD; Wiencek JM; McCray PB; Tack BF; Vogel HJ
J Biol Chem; 2002 Mar; 277(10):8279-89. PubMed ID: 11741980
[TBL] [Abstract][Full Text] [Related]
17. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
Münch D; Sahl HG
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
[TBL] [Abstract][Full Text] [Related]
18. Assay for identification of inhibitors for bacterial MraY translocase or MurG transferase.
Branstrom AA; Midha S; Longley CB; Han K; Baizman ER; Axelrod HR
Anal Biochem; 2000 May; 280(2):315-9. PubMed ID: 10790316
[TBL] [Abstract][Full Text] [Related]
19. Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin.
Billot-Klein D; Shlaes D; Bryant D; Bell D; Legrand R; Gutmann L; van Heijenoort J
J Bacteriol; 1997 Aug; 179(15):4684-8. PubMed ID: 9244253
[TBL] [Abstract][Full Text] [Related]
20. Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity.
Scherer K; Wiedemann I; Ciobanasu C; Sahl HG; Kubitscheck U
Biochim Biophys Acta; 2013 Nov; 1828(11):2628-36. PubMed ID: 23872123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
